The companies, which all sold Zantac at different times, argue that Medinilla should have granted their motion to block ...
GSK’s shares fell sharply following a judge's decision to allow more than 70,000 lawsuits to proceed, alleging it’s Zantac ...
Global pharmaceutical company GlaxoSmithKline (GSK) is under scrutiny as a US judge has permitted over 70,000 lawsuits to ...
GSK results from a Phase 2 study that found Jemperli showed a 100% clinical complete response rate in patients with mismatch ...
The Delaware State Court ruled that expert witnesses can present scientific evidence in the roughly 75,000 cases relating to ...
GSK shares have plunged after a ruling by a Delaware judge that will force the company to face trial by jury for its Zantac ...
The judge's decision, issued late Friday, permits expert witnesses to testify that Zantac may cause cancer. GSK, along with former Zantac manufacturers Pfizer, Sanofi (NASDAQ ... is seen as relatively ...
ALSO READ: GSK faces lawsuit from lab that found probable carcinogen in Zantac "This moves us one step closer to justice for ...
(Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ...
Along with GSK and Pfizer, Sanofi and Boehringer Ingelheim GmbH have been sued by consumers. After the federal cases were ...
Pfizer Inc (NYSE:PFE) released longer-term follow-up results from the Phase 3 CROWN trial evaluating Lorbrena (lorlatinib) ...
The lawsuit claims that Musk and his right-hand man Jared Birchall were aware of and discussed the rule that they have to ...